SAN DIEGO, Feb. 7, 2012 /PRNewswire/ -- ADVENTRX
Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the
Company's Chief Executive Officer, Brian M.
Culley, will present at the 14th Annual BIO CEO &
Investor Conference on Tuesday, February 14,
2012 at 11:00 a.m. Eastern
time, in the Park South Salon at the Waldorf=Astoria Hotel
in New York.
Interested parties can access a live audio webcast and slide
presentation on the ADVENTRX Pharmaceuticals web site at
www.adventrx.com. An archived presentation will be available on the
web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on
developing proprietary product candidates. The Company's lead
product candidate is ANX-188, a rheologic, antithrombotic and
cytoprotective agent that improves micro-vascular blood flow, which
has potential application in treating a wide range of diseases and
conditions, such as complications arising from sickle cell
disease. The Company also is developing ANX-514, a novel,
detergent-free formulation of the chemotherapy drug docetaxel.
More information can be found on the Company's web site at
www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.